APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lysine Specific Demethylase 1 Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lysine Specific Demethylase 1 Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025187 pages

Choose your research edition.

Industry ResearchLysine Specific Demethylase 1 Inhibitor Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Lysine Specific Demethylase 1 Inhibitor Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Lysine Specific Demethylase 1 Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lysine Specific Demethylase 1 Inhibitor Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Lysine Specific Demethylase 1 Inhibitor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lysine Specific Demethylase 1 Inhibitor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lysine Specific Demethylase 1 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lysine Specific Demethylase 1 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lysine Specific Demethylase 1 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lysine Specific Demethylase 1 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lysine Specific Demethylase 1 Inhibitor include 4SC, Beatica, Celgene Corporation, CSPC ZhongQi Pharmaceutical Technology, Oryzon Genomics, Rasna Therapeutic, Salarius Pharmaceuticals and Taiho Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lysine Specific Demethylase 1 Inhibitor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lysine Specific Demethylase 1 Inhibitor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lysine Specific Demethylase 1 Inhibitor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lysine Specific Demethylase 1 Inhibitor market size, projected growth trends, production technologies, key applications, and end-use industries.

Lysine Specific Demethylase 1 Inhibitor Segment by Company

4SC

Beatica

Celgene Corporation

CSPC ZhongQi Pharmaceutical Technology

Oryzon Genomics

Rasna Therapeutic

Salarius Pharmaceuticals

Taiho Pharmaceutical

Lysine Specific Demethylase 1 Inhibitor Segment by Type

Vaccine

Monoclonal Antibody

Lysine Specific Demethylase 1 Inhibitor Segment by Application

Breast Cancer

Prostate Cancer

Others

Lysine Specific Demethylase 1 Inhibitor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysine Specific Demethylase 1 Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lysine Specific Demethylase 1 Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysine Specific Demethylase 1 Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lysine Specific Demethylase 1 Inhibitor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lysine Specific Demethylase 1 Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lysine Specific Demethylase 1 Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lysine Specific Demethylase 1 Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lysine Specific Demethylase 1 Inhibitor Industry Trends Table 2. Lysine Specific Demethylase 1 Inhibitor Industry Drivers Table 3. Lysine Specific Demethylase 1 Inhibitor Industry Opportunities and Challenges Table 4. Lysine Specific Demethylase 1 Inhibitor Industry Restraints Table 5. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lysine Specific Demethylase 1 Inhibitor Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Manufacturers Table 9. Global Lysine Specific Demethylase 1 Inhibitor Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lysine Specific Demethylase 1 Inhibitor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lysine Specific Demethylase 1 Inhibitor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lysine Specific Demethylase 1 Inhibitor Manufacturers, Product Type & Application Table 13. Global Lysine Specific Demethylase 1 Inhibitor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lysine Specific Demethylase 1 Inhibitor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vaccine Table 17. Major Manufacturers of Monoclonal Antibody Table 18. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2026) & (K Units) Table 20. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2027-2032) & (K Units) Table 21. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2021-2026) Table 22. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2027-2032) Table 23. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2026) & (K Units) Table 25. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2027-2032) & (K Units) Table 26. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2021-2026) Table 27. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Breast Cancer Table 29. Major Manufacturers of Prostate Cancer Table 30. Major Manufacturers of Others Table 31. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2026) & (K Units) Table 33. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2027-2032) & (K Units) Table 34. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2021-2026) Table 35. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2027-2032) Table 36. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2026) & (K Units) Table 38. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2027-2032) & (K Units) Table 39. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2021-2026) Table 40. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2027-2032) Table 41. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2021-2026) & (K Units) Table 43. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2021-2026) Table 44. Global Lysine Specific Demethylase 1 Inhibitor Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Lysine Specific Demethylase 1 Inhibitor Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 48. North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 49. Europe Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 51. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 58. Global Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2021-2026) Table 62. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2027-2032) Table 63. 4SC Company Information Table 64. 4SC Business Overview Table 65. 4SC Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. 4SC Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 67. 4SC Recent Development Table 68. Beatica Company Information Table 69. Beatica Business Overview Table 70. Beatica Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Beatica Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 72. Beatica Recent Development Table 73. Celgene Corporation Company Information Table 74. Celgene Corporation Business Overview Table 75. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 77. Celgene Corporation Recent Development Table 78. CSPC ZhongQi Pharmaceutical Technology Company Information Table 79. CSPC ZhongQi Pharmaceutical Technology Business Overview Table 80. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 82. CSPC ZhongQi Pharmaceutical Technology Recent Development Table 83. Oryzon Genomics Company Information Table 84. Oryzon Genomics Business Overview Table 85. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 87. Oryzon Genomics Recent Development Table 88. Rasna Therapeutic Company Information Table 89. Rasna Therapeutic Business Overview Table 90. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 92. Rasna Therapeutic Recent Development Table 93. Salarius Pharmaceuticals Company Information Table 94. Salarius Pharmaceuticals Business Overview Table 95. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 97. Salarius Pharmaceuticals Recent Development Table 98. Taiho Pharmaceutical Company Information Table 99. Taiho Pharmaceutical Business Overview Table 100. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 102. Taiho Pharmaceutical Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Lysine Specific Demethylase 1 Inhibitor Distributors List Table 106. Lysine Specific Demethylase 1 Inhibitor Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Lysine Specific Demethylase 1 Inhibitor Product Image Figure 2. Global Lysine Specific Demethylase 1 Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lysine Specific Demethylase 1 Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global Lysine Specific Demethylase 1 Inhibitor Sales (2021-2032) & (K Units) Figure 5. Global Lysine Specific Demethylase 1 Inhibitor Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lysine Specific Demethylase 1 Inhibitor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vaccine Image Figure 9. Monoclonal Antibody Image Figure 10. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2021-2032) Figure 13. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2021-2032) Figure 16. Breast Cancer Image Figure 17. Prostate Cancer Image Figure 18. Others Image Figure 19. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2021-2032) Figure 22. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2021-2032) Figure 25. North America Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2021-2032) Figure 27. U.S. Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2021-2032) Figure 32. Germany Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2021-2032) Figure 39. China Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2021-2032) Figure 47. Brazil Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Lysine Specific Demethylase 1 Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Lysine Specific Demethylase 1 Inhibitor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Figure 58. North America Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lysine Specific Demethylase 1 Inhibitor Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lysine Specific Demethylase 1 Inhibitor Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Monoclonal Antibody
Applications
  • Breast Cancer
  • Prostate Cancer
  • Others
Companies covered
  • 4SC
  • Beatica
  • Celgene Corporation
  • CSPC ZhongQi Pharmaceutical Technology
  • Oryzon Genomics
  • Rasna Therapeutic
  • Salarius Pharmaceuticals
  • Taiho Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lysine Specific Demethylase 1 Inhibitor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lysine Specific Demethylase 1 Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lysine Specific Demethylase 1 Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lysine Specific Demethylase 1 Inhibitor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lysine Specific Demethylase 1 Inhibitor Market Dynamics
  1. 2.1 Lysine Specific Demethylase 1 Inhibitor Industry Trends
  2. 2.2 Lysine Specific Demethylase 1 Inhibitor Industry Drivers
  3. 2.3 Lysine Specific Demethylase 1 Inhibitor Industry Opportunities and Challenges
  4. 2.4 Lysine Specific Demethylase 1 Inhibitor Industry Restraints
3 Lysine Specific Demethylase 1 Inhibitor Market by Manufacturers
  1. 3.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lysine Specific Demethylase 1 Inhibitor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lysine Specific Demethylase 1 Inhibitor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lysine Specific Demethylase 1 Inhibitor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lysine Specific Demethylase 1 Inhibitor Manufacturers, Product Type & Application
  7. 3.7 Global Lysine Specific Demethylase 1 Inhibitor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lysine Specific Demethylase 1 Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lysine Specific Demethylase 1 Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lysine Specific Demethylase 1 Inhibitor Tier 1, Tier 2, and Tier 3
4 Lysine Specific Demethylase 1 Inhibitor Market by Type
  1. 4.1 Lysine Specific Demethylase 1 Inhibitor Type Introduction
  2. 4.1.1 Vaccine
  3. 4.1.2 Monoclonal Antibody
  4. 4.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type
  5. 4.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2032)
  7. 4.2.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type
  9. 4.3.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2032)
  11. 4.3.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2021-2032)
5 Lysine Specific Demethylase 1 Inhibitor Market by Application
  1. 5.1 Lysine Specific Demethylase 1 Inhibitor Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Others
  5. 5.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application
  6. 5.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2032)
  8. 5.2.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application
  10. 5.3.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2032)
  12. 5.3.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2021-2032)
6 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region
  1. 6.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2021-2032)
  3. 6.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2021-2026)
  4. 6.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region
  1. 7.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region
  2. 7.1.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2021-2026)
  4. 7.1.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2027-2032)
  5. 7.1.4 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032)
  8. 7.2.2 North America Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032)
  11. 7.3.2 Europe Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 4SC
  2. 8.1.1 4SC Company Information
  3. 8.1.2 4SC Business Overview
  4. 8.1.3 4SC Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 4SC Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  6. 8.1.5 4SC Recent Developments
  7. 8.2 Beatica
  8. 8.2.1 Beatica Company Information
  9. 8.2.2 Beatica Business Overview
  10. 8.2.3 Beatica Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beatica Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  12. 8.2.5 Beatica Recent Developments
  13. 8.3 Celgene Corporation
  14. 8.3.1 Celgene Corporation Company Information
  15. 8.3.2 Celgene Corporation Business Overview
  16. 8.3.3 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  18. 8.3.5 Celgene Corporation Recent Developments
  19. 8.4 CSPC ZhongQi Pharmaceutical Technology
  20. 8.4.1 CSPC ZhongQi Pharmaceutical Technology Company Information
  21. 8.4.2 CSPC ZhongQi Pharmaceutical Technology Business Overview
  22. 8.4.3 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  24. 8.4.5 CSPC ZhongQi Pharmaceutical Technology Recent Developments
  25. 8.5 Oryzon Genomics
  26. 8.5.1 Oryzon Genomics Company Information
  27. 8.5.2 Oryzon Genomics Business Overview
  28. 8.5.3 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  30. 8.5.5 Oryzon Genomics Recent Developments
  31. 8.6 Rasna Therapeutic
  32. 8.6.1 Rasna Therapeutic Company Information
  33. 8.6.2 Rasna Therapeutic Business Overview
  34. 8.6.3 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  36. 8.6.5 Rasna Therapeutic Recent Developments
  37. 8.7 Salarius Pharmaceuticals
  38. 8.7.1 Salarius Pharmaceuticals Company Information
  39. 8.7.2 Salarius Pharmaceuticals Business Overview
  40. 8.7.3 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  42. 8.7.5 Salarius Pharmaceuticals Recent Developments
  43. 8.8 Taiho Pharmaceutical
  44. 8.8.1 Taiho Pharmaceutical Company Information
  45. 8.8.2 Taiho Pharmaceutical Business Overview
  46. 8.8.3 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  48. 8.8.5 Taiho Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lysine Specific Demethylase 1 Inhibitor Value Chain Analysis
  2. 9.1.1 Lysine Specific Demethylase 1 Inhibitor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lysine Specific Demethylase 1 Inhibitor Production Mode & Process
  6. 9.2 Lysine Specific Demethylase 1 Inhibitor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lysine Specific Demethylase 1 Inhibitor Distributors
  9. 9.2.3 Lysine Specific Demethylase 1 Inhibitor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst